Botulin therapy for chronic migraine
Автор: Istomina E.V., Gruzdeva N.I.
Журнал: Вестник медицинского института "РЕАВИЗ": реабилитация, врач и здоровье @vestnik-reaviz
Рубрика: Клиническая медицина
Статья в выпуске: 2 т.13, 2023 года.
Бесплатный доступ
This article presents a review of current modern research on the use of botulinum toxin therapy for the prevention and treatment of patients with chronic migraine, as well as briefly outlines current views on the pathogenesis of migraine, its impact on quality of life and patients' ability to work. Botulinum toxin A is currently the drug of first choice for the treatment of chronic migraine. Numerous studies confirm the effectiveness and safety of its use in clinical practice.
Migraine, chronic migraine, headache, working ability, botulinum toxin type a
Короткий адрес: https://sciup.org/143180197
IDR: 143180197 | DOI: 10.20340/vmi-rvz.2023.2.CLIN.2